Histoplasmosis in Solid Organ Transplant Recipients | Zendy

Chadi A. Hage | Zendy; Martin B. Kleiman | Zendy; L. Joseph Wheat | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Histoplasmosis in Solid Organ Transplant Recipients

Author(s) -

Chadi A. Hage,

Martin B. Kleiman,

L. Joseph Wheat

Publication year - 2009

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/649056

Subject(s) - medicine , histoplasmosis , solid organ , organ transplantation , dermatology , histoplasma , intensive care medicine , immunology , transplantation , histoplasma capsulatum

NOTE. TNF, tumor necrosis factor. envelope cholesterol in virus entry and infection. J Virol 2003; 77:12543–51. 5. van de Beek D, Kremers WK, Del Pozo JL, et al. Effect of infectious diseases on outcome after heart transplant. Mayo Clin Proc 2008; 83: 304–8. 6. van de Beek D, Patel R, Daly RC, McGregor CG, Wijdicks EF. Central nervous system infections in heart transplant recipients. Arch Neurol 2007; 64:1715–20. 7. Niessner A, Steiner S, Speidl WS, et al. Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis 2006; 189:408–13. 8. Itabashi S, Arai H, Matsui T, Higuchi S, Sasaki H. Herpes simplex virus and risk of Alzheimer’s disease. Lancet 1997; 349:1102.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research